Search

Your search keyword '"Yan, Bryan Ping-Yen"' showing total 17 results
Start Over Author "Yan, Bryan Ping-Yen"
17 results on '"Yan, Bryan Ping-Yen"'

2. Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia

Author

Kawarada, Osami, Hozawa, Koji, Zen, Kan, Huang, Hsuan-Li, Kim, Su Hong, Choi, Donghoon, Park, Kihyuk, Kato, Kenichi, Kato, Taku, Tsubakimoto, Yoshinori, Ichihashi, Shigeo, Fujimura, Naoki, Higashimori, Akihiro, Sato, Tomoyasu, Yan, Bryan Ping-Yen, Pang, Skyi Yin-Chun, Wongwanit, Chumpol, Leong, Yew Pung, Chua, Benjamin, George, Robbie K., Chen, I-Chih, Lee, Jen-Kuang, Hsu, Chung-Ho, Pua, Uei, Iwata, Yo, Miki, Kojiro, Okada, Kozo, and Obara, Hideaki

Published
2020
Full Text
View/download PDF

4. Contemporary critical limb ischemia: Asian multidisciplinary consensus statement on the collaboration between endovascular therapy and wound care

Author

Kawarada, Osami, Zen, Kan, Hozawa, Koji, Ayabe, Shinobu, Huang, Hsuan-Li, Choi, Donghoon, Kim, Su Hong, Kim, Jiyoun, Kato, Taku, Tsubakimoto, Yoshinori, Nakama, Tasuya, Ichihashi, Shigeo, Fujimura, Naoki, Higashimori, Akihiro, Fujihara, Masahiko, Sato, Tomoyasu, Yan, Bryan Ping-Yen, Pang, Skyi Yin-Chun, Wongwanit, Chumpol, Leong, Yew Pung, Chua, Benjamin, George, Robbie K., Yokoi, Yoshiaki, Motomura, Hisashi, and Obara, Hideaki

Published
2018
Full Text
View/download PDF

9. Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia

Author

Kawarada, Osami, primary, Hozawa, Koji, additional, Zen, Kan, additional, Huang, Hsuan-Li, additional, Kim, Su Hong, additional, Choi, Donghoon, additional, Park, Kihyuk, additional, Kato, Kenichi, additional, Kato, Taku, additional, Tsubakimoto, Yoshinori, additional, Ichihashi, Shigeo, additional, Fujimura, Naoki, additional, Higashimori, Akihiro, additional, Sato, Tomoyasu, additional, Yan, Bryan Ping-Yen, additional, Pang, Skyi Yin-Chun, additional, Wongwanit, Chumpol, additional, Leong, Yew Pung, additional, Chua, Benjamin, additional, George, Robbie K., additional, Chen, I-Chih, additional, Lee, Jen-Kuang, additional, Hsu, Chung-Ho, additional, Pua, Uei, additional, Iwata, Yo, additional, Miki, Kojiro, additional, Okada, Kozo, additional, and Obara, Hideaki, additional

Published
2019
Full Text
View/download PDF

15. Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation.

Author

Vivian Wing-Yan Lee, Ronald Bing-Ching Tsai, Ines Hang-Iao Chow, Bryan Ping-Yen Yan, Kaya, Mehmet Gungor, Park, Jai-Wun, Yat-Yin Lam, Lee, Vivian Wing-Yan, Tsai, Ronald Bing-Ching, Chow, Ines Hang-Iao, Yan, Bryan Ping-Yen, and Lam, Yat-Yin

Subjects
MITRAL valve diseases, STROKE prevention, ATRIAL fibrillation, COST effectiveness, QUALITY of life, ATRIAL fibrillation treatment, HEART atrium, DECISION making, CARDIAC surgery, MYOCARDIAL depressants, STROKE, QUALITY-adjusted life years, STATISTICAL models, DISEASE complications, ECONOMICS, SURGERY, THERAPEUTICS
Abstract

Background: Transcatheter left atrial appendage occlusion (LAAO) is a promising therapy for stroke prophylaxis in non-valvular atrial fibrillation (NVAF) but its cost-effectiveness remains understudied. This study evaluated the cost-effectiveness of LAAO for stroke prophylaxis in NVAF.Methods: A Markov decision analytic model was used to compare the cost-effectiveness of LAAO with 7 pharmacological strategies: aspirin alone, clopidogrel plus aspirin, warfarin, dabigatran 110 mg, dabigatran 150 mg, apixaban, and rivaroxaban. Outcome measures included quality-adjusted life years (QALYs), lifetime costs and incremental cost-effectiveness ratios (ICERs). Base-case data were derived from ACTIVE, RE-LY, ARISTOTLE, ROCKET-AF, PROTECT-AF and PREVAIL trials. One-way sensitivity analysis varied by CHADS2 score, HAS-BLED score, time horizons, and LAAO costs; and probabilistic sensitivity analysis using 10,000 Monte Carlo simulations was conducted to assess parameter uncertainty.Results: LAAO was considered cost-effective compared with aspirin, clopidogrel plus aspirin, and warfarin, with ICER of US$5,115, $2,447, and $6,298 per QALY gained, respectively. LAAO was dominant (i.e. less costly but more effective) compared to other strategies. Sensitivity analysis demonstrated favorable ICERs of LAAO against other strategies in varied CHADS2 score, HAS-BLED score, time horizons (5 to 15 years) and LAAO costs. LAAO was cost-effective in 86.24 % of 10,000 simulations using a threshold of US$50,000/QALY.Conclusions: Transcatheter LAAO is cost-effective for prevention of stroke in NVAF compared with 7 pharmacological strategies. The transcatheter left atrial appendage occlusion (LAAO) is considered cost-effective against the standard 7 oral pharmacological strategies including acetylsalicylic acid (ASA) alone, clopidogrel plus ASA, warfarin, dabigatran 110 mg, dabigatran 150 mg, apixaban, and rivaroxaban for stroke prophylaxis in non-valvular atrial fibrillation management. [ABSTRACT FROM AUTHOR]

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results